FIELD: medicine, pharmacology, biotechnology.
SUBSTANCE: composition comprises a mixture of flavolignans (silybin, silydianin and silychristin) from spotted milk thistle, mixture of purified lipids and glycine, and can comprise essential L-amino acids, and some vegetable extracts. Invention provides the enhanced antitoxic and anti-apoptosis effect with respect to not only liver and digestion organs cells but and for other cellular systems of body based on synergistic effect of all components of the biocomposition. Invention can be used for prophylaxis of different ecologically unfavorable effects and effect of carcinogenic factors being especially on humans.
EFFECT: valuable medicinal properties of biocomposition.
4 cl, 2 tbl, 2 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR THERAPY OF HEPATIC PATHOLOGIES AND ONCOLOGICAL DISEASES | 2008 |
|
RU2379046C1 |
| ANTITUMOR LIPOSOMAL PREPARATION WITH DIRECTED EFEFCT | 2005 |
|
RU2292898C1 |
| PROPHYLAXIS COMPOSITION BASED ON PHENOLIC SUBSTANCES AND PHOSPHOLIPIDS | 2006 |
|
RU2306945C1 |
| USE OF FLAVONOLIGNANS FOR INHIBITION OF EXCESSIVE AND PATHOLOGICAL PROLIFERATION OF VESSEL ENDOTHELIUM | 2005 |
|
RU2291706C1 |
| PREVENTIVE COMPOSITION BASED ON SUBSTANCES OF PHENOL NATURE | 2008 |
|
RU2354395C1 |
| COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGICAL DISEASE | 2005 |
|
RU2311917C2 |
| AGENT AND METHOD FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGY DISEASES | 2005 |
|
RU2283658C1 |
| METHOD OF OBTAINING DRY EXTRACT OF MILK THISTLE | 2009 |
|
RU2424818C1 |
| METHOD FOR PREPARING AGENT HAVING HEPATOPROTECTIVE AND CHOLERETIC EFFECT | 2023 |
|
RU2828000C1 |
| INJECTION DRUG FORM FOR TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS | 2012 |
|
RU2504347C1 |
